Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Alopecia areata shows various signs on the skin that aid in diagnosis and prognosis, with certain features indicating more severe disease.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Upadacitinib may effectively treat alopecia areata without side effects.

Male gender and family history predict alopecia areata recurrence.

People with severe hair loss have lower zinc levels in their blood.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Low vitamin D levels are common in people with Alopecia Areata.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Balding men have harder scalps.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.